<- Go Home
IntriCon Corporation
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota. As of May 24, 2022, IntriCon Corporation was taken private.
Market Cap
$225.5M
Volume
61.0K
Cash and Equivalents
$5.3M
EBITDA
$7.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$32.0M
Profit Margin
25.33%
52 Week High
$25.15
52 Week Low
$12.47
Dividend
N/A
Price / Book Value
2.41
Price / Earnings
-150.13
Price / Tangible Book Value
3.17
Enterprise Value
$211.2M
Enterprise Value / EBITDA
21.30
Operating Income
$1.6M
Return on Equity
1.43%
Return on Assets
0.81
Cash and Short Term Investments
$20.8M
Debt
$6.4M
Equity
$93.8M
Revenue
$126.5M
Unlevered FCF
-$8.2M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium